Aberrant endothelial CXCL signaling in COPD
N. Kothapalli (New Haven, CT, United States of America), J. Mcdonough (New Haven, CT, United States of America), M. Raredon (New Haven, CT, United States of America), T. Adams (New Haven, CT, United States of America), J. Schupp (New Haven, CT, United States of America), L. Niklason (New Haven, CT, United States of America), N. Kaminski (New Haven, CT, United States of America), I. Rosas (Houston, TX, United States of America), M. Sauler (New Haven, CT, United States of America)
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kothapalli (New Haven, CT, United States of America), J. Mcdonough (New Haven, CT, United States of America), M. Raredon (New Haven, CT, United States of America), T. Adams (New Haven, CT, United States of America), J. Schupp (New Haven, CT, United States of America), L. Niklason (New Haven, CT, United States of America), N. Kaminski (New Haven, CT, United States of America), I. Rosas (Houston, TX, United States of America), M. Sauler (New Haven, CT, United States of America). Aberrant endothelial CXCL signaling in COPD. 3623
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: